Platelets to Lymphocytes Ratio in Sepsis

NCT05399225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-06-01

No results posted yet for this study

Summary

The aim of this study is to compare effectiveness of platelets to lymphocytes ratio (PLR) with procalcitonin as a predictor of sepsis outcome.

Conditions

  • Platelets to Lymphocytes Ratio Sepsis

Interventions

DIAGNOSTIC_TEST

Platelets to lymphocytes ratio and procalcitonin

Platelets to lymphocytes ratio and procalcitonin in sepsis

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05399225 on ClinicalTrials.gov